Natural thiopeptides as a privileged scaffold for drug discovery and therapeutic development

被引:0
|
作者
Xiaoqi Shen
Muhammad Mustafa
Yanyang Chen
Yingying Cao
Jiangtao Gao
机构
[1] Fujian Agriculture and Forestry University,College of Life Sciences
来源
关键词
Thiopeptides; Natural products; Antimicrobial activity; Biosynthesis;
D O I
暂无
中图分类号
学科分类号
摘要
Since the start of the 21st century, antibiotic drug discovery and development from natural products has experienced a certain renaissance. Currently, basic scientific research in chemistry and biology of natural products has finally borne fruit for natural product-derived antibiotics drug discovery. A batch of new antibiotic scaffolds were approved for commercial use, including oxazolidinones (linezolid, 2000), lipopeptides (daptomycin, 2003), and mutilins (retapamulin, 2007). Here, we reviewed the thiazolyl peptides (thiopeptides), an ever-expanding family of antibiotics produced by Gram-positive bacteria that have attracted the interest of many research groups thanks to their novel chemical structures and outstanding biological profiles. All members of this family of natural products share their central azole substituted nitrogen-containing six-membered ring and are classified into different series. Most of the thiopeptides show nanomolar potencies for a variety of Gram-positive bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and penicillin-resistant Streptococcus pneumonia (PRSP). They also show other interesting properties such as antiplasmodial and anticancer activities. The chemistry and biology of thiopeptides has gathered the attention of many research groups, who have carried out many efforts towards the study of their structure, biological function, and biosynthetic origin. Here we reviewed a total of 119 natural thiopeptides discovered during the last 50 years. Moreover, we summarized biological profiles, mechanisms of action, and biosynthesis of these thiopeptides.
引用
收藏
页码:1063 / 1098
页数:35
相关论文
共 50 条
  • [31] Nitroheterocyclic derivatives: privileged scaffold for drug development against Chagas disease
    Scarim, Caue Benito
    Chin, Chung Man
    MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (12) : 2099 - 2108
  • [32] Cyclotides, a novel natural peptide scaffold for drug discovery
    Jagadish, Krishnappa
    Ji, Yanbin
    Bi, Tao
    Berrade, Luis
    Camarero, Julio A.
    BIOPOLYMERS, 2011, 96 (04) : 449 - 449
  • [33] Privileged Structures in Drug Discovery
    Tomasic, Tihomir
    CHEMMEDCHEM, 2020, 15 (08) : 726 - 726
  • [34] Indazole as a Privileged Scaffold: The Derivatives and their Therapeutic Applications
    Qin, Jinling
    Cheng, Weyland
    Duan, Yong-Tao
    Yang, Hua
    Yao, Yongfang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (07) : 839 - 860
  • [35] Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA-approved drugs and clinical candidates
    Sharma, Venu
    Sharma, Ankita
    Wadje, Bhagyashri N.
    Bharate, Sandip B.
    MEDICINAL RESEARCH REVIEWS, 2024, 44 (05) : 2035 - 2077
  • [36] The Chromenopyridine Scaffold: A Privileged Platform in Drug Design
    de Lima, Fabio Pedroso
    Costa, Marta
    Sousa, Ana
    Proenca, Maria Fernanda
    MOLECULES, 2024, 29 (13):
  • [37] 1,3,4-thiadiazole: A Privileged Scaffold for Drug Design and Development
    Han, Xu
    Yu, Yun Long
    Hu, Yang Sheng
    Liu, Xin Hua
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2021, 21 (28) : 2546 - 2573
  • [38] Privileged structures: Applications in drug discovery
    DeSimone, RW
    Currie, KS
    Mitchell, SA
    Darrow, JW
    Pippin, DA
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2004, 7 (05) : 473 - 493
  • [39] Diarylheptanoid: A privileged structure in drug discovery
    Sun, De-Juan
    Zhu, Ling-Juan
    Zhao, Yu-Qian
    Zhen, Yong-Qi
    Zhang, Lan
    Lin, Cong-Cong
    Chen, Li-Xia
    FITOTERAPIA, 2020, 142
  • [40] Natural products in drug discovery and development
    Sandsborg, WNAR
    BIOASSAY METHODS IN NATURAL PRODUCT RESEARCH AND DRUG DEVELOPMENT, 1999, 43 : 143 - 149